The department of psychiatry and neurobehavioral sciences, division child and family psychiatry is seeking children ages 6-17 with Tourette ’s syndrome for a research study. The purpose of the study is evaluate the safety and efficacy of the study drug (ecopipam).
Your child may be eligible for this study if they are 6-17 years old and have been diagnosed with Tourette’s syndrome.
This study involves blood draws, ECGs, physical exams, psychiatric assessments, and taking the study medication/placebo daily. There will be approximately 11 visits to the study center over 4-5 months.
The study drug and all study-related medical tests and procedures are provided at no cost to qualified participants.